Vaccines

President taps internal medicine physician with government experience.

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

Approval is for use among adults 60 and older

Agency authorizes single-shot bivalent vaccinations, ends authorization for monovalent vaccines

The provision requiring various preventive coverages is being challenged in court

Retail giant expanding into two new states, with additional growth in Texas.

A conversation with AAFP President Tochi Iroku-Malize, M.D., M.P.H., M.B.A.

Steps toward improvement include more access to primary care.

BD says results could be available within two hours.

Abrupt cutoff ‘would create wide-ranging chaos’ in health care, White House says.

Attorneys general file petition to withdraw requirement.

Administration pushes for vaccines and boosters for the fall.

Agency seeks to reduce exposure risks as in-person schooling resumes

Study links discrepancy to adults’ misbeliefs about vaccine safety

Jason Lee, M.S., Ph.D.(c), and John J. Russell, M.D., discuss the cost associated with influenza and how vaccination can provide cost savings.

AAFP president discusses endorsement, patient approaches, next round of shots.

Drs. Jason Lee and John J. Russell discuss the impact of chronic health conditions on adults.

Vaccine experts discuss racial disparities and the impact on influenza vaccinations.

Four for adult vaccines effective immediately, four pending approval for youths.

Jason Lee, M.S., Ph.D.(c), and John J. Russell, M.D., address vaccine hesitancy and gaps in influenza vaccines in adults.

Jason Lee, M.S., Ph.D.(c), discusses results and takeaways from the study of a high-dose influenza vaccine in older adults.

Company claims rivals copied proprietary mRNA technology to make shots.

Jason Lee, M.S., Ph.D.(c), discusses the rationale, objectives, and methods for a study of the efficacy and effectiveness of a high-dose influenza vaccine in older adults.

Jason Lee, M.S., Ph.D.(c), discusses the background to seasonal influenza.

Back-to-school season is prime time to reach parents and children about immunizations.

Codes enable billing for lab tests, administering vaccines

The pandemic underscored the incredible power of vaccination.

The move will delay the vaccine’s authorization for this younger group.

An EUA for the smaller shots would plug a hole in the nation’s vaccination strategy.

Spikevax is now the second COVID-19 vaccine approved by US regulators.